Template:Cycloserine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 19: Line 19:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cycloserine overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cycloserine overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cycloserine clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cycloserine dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cycloserine dosage and administration|Dosage and Administration]]

Latest revision as of 21:22, 26 December 2013